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Abstract
For-Thp–Leu–Ain-OMe and for-Met–Dz Leu–Phe-OMe are two conformationally restricted fMLP-OMe analogues able
to discriminate between different biological responses of human neutrophils. In this paper, we demonstrate that the former
peptide, which evokes only chemotaxis, does not alter human neutrophil Ca2q levels. In contrast, for-Met–Dz Leu–Phe-OMe,
which induces superoxide anion release and degranulation but not chemotaxis, significantly increases the cation concentra-
tion. The chelation of Ca2q in both extracellular and intracellular media abolishes Oy production triggered by for-Met–2
Dz Leu–Phe-OMe, while the same procedure does not affect neutrophil chemotaxis towards for-Thp–Leu–Ain-OMe. We
therefore suggest that chemotaxis, unlike superoxide anion release, is independent of Ca2q enhancement in human
neutrophils. q 1997 Elsevier Science B.V.
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1. Introduction
Several elements of the signal transduction se-
quence leading to the activation of neutrophils by
chemoattractants are known from many years. The
binding of the prototypical formyltripeptide for-Met–
 .Leu–Phe fMLP to its receptors, on neutrophil
plasma membrane, generates multiple intracellular
second messengers through the activation of phos-
pholipases C, A and D, as well as the stimulation of2
) Corresponding author. Fax: 39 532 202 723; E-mail:
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w xtyrosine kinase and phosphatidyl inositol 3-kinase 1 .
X X  .Adenosine 3 ,5 -cyclic monophosphate cAMP syn-
thesis has also been demonstrated in neutrophils in
w xresponse to fMLP 2,3 . We and others have recently
reported that the nucleotide may be an additional
intracellular messenger involved in neutrophil physio-
w xlogical actions 4,5 .
An unresolved question is which of these sig-
nalling pathways are important for the various neu-
trophil functions, i.e. adhesion, chemotaxis, degranu-
 y.lation, phagocytosis, and superoxide anion O pro-2
duction. Compounds able to select between the dif-
ferent responses may shed light on this matter.
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Fig. 1. Structures of the fMLP-OMe and of the two synthetic
ligands 2 and 3.
We have previously reported studies on two
 .fMLP-OMe 1 analogues, namely for-Thp–Leu–
w 1 3x .  .Ain-OMe Thp , Ain fMLP-OMe 2 and for-
z w z 2 x .  .Met–D Leu–Phe-OMe D Leu fMLP-OMe 3
w x6,7 . The structures of these two synthetic ligands
 .see Fig. 1 are characterized by the presence of
w 1 3xunnatural a-aminoacids. In particular, in Thp , Ain ,
the native external residue of Met and Phe has been
replaced by 4-amino-tetrahydrothiopyran-4-carbo-
 .xylic acid Thp and 2-aminoindane-2-carboxylic acid
 . w z 2 xAin , respectively. In D Leu , the central Leu has
 .  z .been replaced by Z -2,3-didehydroleucine D Leu .
Although the three synthetic residues maintain close
structural similarity with the corresponding natural
aminoacids, they can determine a significant reduc-
tion of the peptide backbone flexibility inducing, at
the same time, the adoption of preferred conforma-
tions. The resulting ‘‘conformationally constrained’’
analogues of the natural peptide ligand are expected
to show selective activity and to give information on
the nature of bioactive conformations. In accordance
with the above considerations, we have previously
found that while fMLP-OMe, like fMLP, is able to
induce a full response by neutrophils, the two ana-
logues exhibit a different and selective behavior. In
w 1 3xparticular, Thp , Ain is only chemoattractant,
w z 2 x ywhereas D Leu is only able to elicit O produc-2
w xtion and degranulation 6,7 . Moreover, the two con-
formationally constrained analogues exert a different
influence on neutrophil transduction pathways. In
w z 2 xfact, D Leu induces, similarly to fMLP-OMe, a
considerable enhancement of cAMP intracellular lev-
w 1 3xels; Thp , Ain , on the other hand, causes only an
increase of the nucleotide concentration which does
w xnot reach statistical significance 3,4 .
The ability of the two conformationally con-
strained analogues to distinguish between different
transduction mechanisms as well as physiological
responses, renders them useful tools for studies tend-
ing to relate specific neutrophil functions to specific
second messenger pathways.
The present study was designed to determine the
influence of the two fMLP-OMe analogues on human
2q w 2qx .neutrophil intracellular Ca concentration Ca i
and to evaluate the sensitivity of cellular responses,
such as chemotaxis and Oy production, to variations2
of Ca2q availability. The cation is, in fact, a second
messenger clearly involved in the activation of neu-
trophils by fMLP.
2. Materials and methods
2.1. Materials
Dextran and Ficoll-Paque were purchased from
 .Pharmacia Uppsala, Sweden . fMLP-OMe, ferricy-
tochrome c, superoxide dismutase, cytochalasin B,
Fura-2, Fura-2 AM, and N, N, N, N-tetrakis 2-pyri-
.  .dylmethyl ethylendiamine TPEN were from Sigma
 .  .St. Louis, MO, USA . 1,2-Bis- 2-aminophenoxy -
ethane-N, N, N X, N X-tetracetic acidracetoxy meth-
 .ylester BAPTArAM was a kind gift from Prof. F.
Di Virgilio, Institute of General Pathology, Univer-
sity of Ferrara. All other reagents were of the purest
grade commercially available.
2.2. Peptides
w 1 3xFor-Thp–Leu–Ain-OMe Thp , Ain and for-
z w z 2 xMet–D Leu–Phe-OMe D Leu were prepared as
w xdescribed previously 6,7 . Peptide stock solutions,
10y2 M in dimethyl sulphoxide, were diluted before
use in neutrophil buffer. The vehicle used did not
interfere with any of the biological assays performed.
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2.3. Cell preparation
Neutrophils were purified by using the standard
dextran sedimentation techniques for heparinized
blood, followed by centrifugation on Ficoll-Paque, as
w xdescribed previously 8 . Neutrophils were harvested
from the bottom of the tube, treated with hypotonic
solution to lyse erythrocytes, washed twice and resus-
pended in Krebs–Ringer–phosphate containing 0.1%
 .  .wrv glucose KRPG , pH 7.4. 1 mM CaCl was2
added to this buffer, where indicated. The percentage
of neutrophils was 99–100% and )98% viable, as
determined by Trypan blue exclusion.
2.4. Cell loading and fluorescence recording
Cells were incubated in total darkness with 1 mM
Fura 2-AM for 30 min at 378C. Under these condi-
tions, Fura 2 reached a concentration of about
110 pmolr106 cells, as calculated comparing loaded
samples with Fura 2-free acid calibration curves.
Before fluorescence recording, neutrophils were di-
luted to 1.5=106rml with the KRPG buffer supple-
mented with 1 mM CaCl , washed and resuspended2
at the same concentration. Throughout the experi-
ment, cells were kept in the dark and used within
2–3 h. Fluorescence measurements were performed at
378C on 2 ml-cuvette, using a Perkin-Elmer LS-5
luminescence spectrofluorimeter equipped with a
thermostatic cuvette and a stirring unit. Emission and
excitation wavelengths were 340 and 505 nm, respec-
tively. For each sample, fluorescence calibration was
carried out in the presence of 2.5 mM EGTA and
0.05% Triton X-100 to obtain the minimum fluores-
 .cence F , and then in the presence of 5.0 mMmin
CaCl providing the maximum fluorescence. Possible2
heavy metal contamination was tested by using TPEN.
Autofluorescence of unloaded cells and all the sub-
stances used in the experiments were checked, cor-
recting F and F values where necessary. Basalmin max
w 2qxand stimulated Ca were calculated according toi
w 2qx  .  .the formula Ca nMsK FyF r F yF ,d min max
 .where K 224 nM is the apparent dissociation con-d
w xstant according to Grynkiewicz et al. 9 .
w 2qx  .Basal Ca was 92.4"4 nM ns50 . 10 mli
drug solutions were added to the cells and fluores-
cence increase was recorded until peak intensity was
achieved; this value represents the maximum intra-
cellular free Ca2q concentration in every preparation
studied.
2.5. Random locomotion and chemotaxis
Assays were evaluated by using a 48-well micro
 .chemotaxis chamber BioProbe, Milan, Italy . Cell
migration in the absence or in the presence of the
chemotactic factor was evaluated by estimating the
 .distance in mm that the leading-front of the cell
migrated, by using the method of Zigmond and Hirsch
w x10 .
Data are expressed in terms of chemotactic index,
which is the ratio migration towards test attractant
.minus migration towards the buffer rmigration to-
wards the buffer.
2.6. Superoxide anion production
Oy release was continuously monitored in a tem-2
perature-controlled spectrophotometer by the reduc-
tion of ferricytochrome c inhibited by superoxide
w xdismutase, as described elsewhere 8 . Briefly, at zero
y6 w z 2 xtime 10 M fMLP-OMe or D Leu was added,
and the amount of Oy produced was calculated by2
the difference in absorbance of the samples with or
without superoxide dismutase, using a 15.5 mM ex-
tinction coefficient at 550 nm for cytochrome c re-
duction. The net nmoles of Oy released were calcu-2
lated by using the formula: stimulated neutrophils
minus resting neutrophils. Neutrophils were incu-
bated with 5mgrml cytochalasin B for 5 min prior to
peptide activation.
2.7. Use of Ca2q chelators
Neutrophils, suspended in Ca2q-free KRPG sup-
plemented with 1 mM EGTA, were incubated for
30 min at 378C in the absence or in the presence of
10 mM intracellular calcium-chelator BAPTArAM.
After washing, each group of cells was incubated for
a further period of 30 min in Ca2q-free KRPG, sup-
plemented with 1 mM EGTA or 1 mM Ca2q as re-
 .ported in the scheme. As control condition A , neu-
trophils incubated in the absence of Ca2q chelators
were utilized.
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30 min at 378C 30 min at 378C
2qCondition A y washing 1 mM Ca
Condition B 1 mM EGTA washing 1 mM EGTA
2qCondition C 1 mM EGTA q10 mM BAPTArAM washing 1 mM Ca
Condition D 1 mM EGTA q10 mM BAPTArAM washing 1 mM EGTA
2qCondition E 1 mM EGTA washing 1 mM Ca
2.8. Statistical analysis
Graphical expression of data and statistical analy-
 .sis Student’s t test were carried out by using the
 .Sigma Plot Jandel Scientific computer program.
Differences were considered statistically significant
at P values -0.05.
3. Results
3.1. Ca2q transients
Challenge of Fura 2-loaded human neutrophils with
increasing concentrations of fMLP-OMe results in a
w 2qx  .dose-dependent elevation of Ca Fig. 2 . Afteri
adding the chemoattractant, the effect is detectable
within a few seconds as a transient increase in fluo-
rescence; this becomes statistically significant P-
. y120.02 at 10 M peptide concentration. Maximum
 .increase 504% versus the basal level is achieved at
a dose of 10y6 M. The constrained fMLP-OMe ana-
w z 2 x y w xlogue D Leu , selective for O production 7 , also2
w 2qxtransiently enhances Ca ; its effect reaches statis-i
 .tical significance P-0.05 at a concentration of
y9  . y610 M and becomes maximal 278% at 10 M. In
w 1 3xcontrast, the analogue Thp , Ain , selective for
w xchemotaxis 6 , is completely ineffective on neu-
w 2qxtrophil Ca .i
w 2qxObservations of Ca changes in human neu-i
trophils pretreated with Ca2q chelators are listed in
Table 1. In condition B extracellular calcium is
omitted and possible contamination avoided by addi-
. y6tion of 1 mM EGTA , 10 M fMLP-OMe and
w z 2 x w 2qxD Leu again increase neutrophil Ca , althoughi
 .to a lesser extent than in condition A control . A
similar trend is observed when the intracellular Ca2q
 . 2qis chelated condition C . On the contrary, in Ca -
depleted and chelator-loaded neutrophils condition
. w 2qxD , Ca does not rise after treatment with ago-i
2q nists; however, when cells are Ca -repleted condi-
.tion E , the effect of the peptides is fully restored. In
w 1 3xall the experimental conditions, Thp , Ain main-
w 2qxtains its inability to affect neutrophil Ca .i
To answer the question whether or not phospholi-
 . 2qpase C PLC is involved in the Ca signalling
coupled to formyl peptide receptors, the enzyme in-
w xhibitor U73122 11 was utilized. As shown in Fig. 3,
transient increases of fluorescence generated by
y6 w z 2 x10 M fMLP-OMe and D Leu are progressively
reduced by increasing blocker concentrations. Inhibi-
tion becomes statistically significant at 0.5 mM drug
concentration, and Ca2q elevation is completely abol-
ished by a 1 mM concentration.
3.2. Neutrophil functionality
w 2qxIn order to investigate the role of Ca increasei
during cellular responses, we measured superoxide
 . w z 2 x  . w 1Fig. 2. Effects of fMLP-OMe ‘ , D Leu ’ , and Thp ,
3x  . w 2q xAin ^ on neutrophil cytosolic Ca . Data are means"SEM
of at least eight determinations. Basal Ca2q level was 92.4"4 nM
 . )ns50 . concentration at which peptide effect becomes statis-
tically significant.
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Table 1
Effect of Ca2q chelators on calcium intracellular levels in neutrophils stimulated by formylpeptides
Formylpeptide Experimental conditions
A B C D E
a b bfMLP-OMe 511"29 216"13 174"1.6 100"1.1 535"53
z 2 a b bw xD Leu 260"20 170"12 155"10 100"2.1 250"18
1 3w xThp , Ain 100"2.3 98"3.1 101"2.4 102"3.0 100"4.0
w z 2 x w 1 3x y6Data are expressed as % of basal level " SEM, which was 92.4"4 nM. fMLP-OMe, D Leu and Thp , Ain were 10 M. For
experimental conditions, see Sections 2 and 2.7. Data are means of at least four separate determinations.
a P-0.001.
b P-0.0001 versus condition A.
anion production as well as chemotaxis by peptide-
activated neutrophils, in both the absence and in the
presence of cation chelators. The highest superoxide
  ..anion release triggered by fMLP-OMe Fig. 4 A
w z 2 x   ..and D Leu Fig. 4 B is achieved in condition A
 . control . A statistically significant reduction P-
. y0.01 at all agonist concentrations of O release is2
obtained when neutrophils are incubated in the ab-
 .sence of intracellular calcium condition C ; the inhi-
bition is even more evident when the extracellular
2q  .Ca is chelated condition B . The response is com-
pletely abolished in Ca2q-depleted and chelator-
 .loaded condition D ; full responsiveness is restored
when neutrophils pretreated with EGTA are Ca2q-re-
Fig. 3. Effect of the phospholipase C inhibitor U 73122 on the
w 2q xD Ca induced by formylpeptides. One representative experi-i
ment out of at least four experiments is shown in the figure.
 .Results are expressed as fluorescence changes arbitrary units .
 .   .  ..pleted condition E , Fig. 4 A and B . In all the
w 1 3xexperimental conditions, Thp , Ain maintains its
y  .inability to induce O release not shown .2
Neutrophils treated with the same procedures de-
scribed above were then utilized to study cell chemo-
2q  .  .Fig. 4. Effects of Ca chelators on A fMLP-OMe- or B
w z 2 xD Leu -induced superoxide anion production by human neu-
trophils. Data are means"SEM of at least four determinations.
 .  .  .  .I : condition A; v : condition B; % : condition C; B :
 .condition D, and ’ : condition E of the Section 2.7 in Section
2.
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Table 2
Effect of Ca2q chelators on neutrophil chemotaxis towards formylpeptides
Formylpeptide Experimental conditions
A B C D E
y1110 M fMLP-OMe 0.85"0.06 0.83"0.04 0.81"0.07 0.78"0.05 0.76"0.06
y910 M fMLP-OMe 1.15"0.10 0.98"0.05 1.11"0.09 0.97"0.06 1.03"0.08
y610 M fMLP-OMe 0.58"0.05 0.52"0.03 0.49"0.04 0.50"0.03 0.57"0.04
y9 1 3w x10 M Thp , Ain 1.47"0.12 1.56"0.11 1.25"0.12 1.17"0.14 1.24"0.11
y10 z 2w x10 M D Leu 0.16"0.01 0.15"0.01 0.18"0.01 0.16"0.02 0.17"0.01
Data are expressed as chemotactic index " SEM, and are the means of at least six separate determinations. For experimental conditions,
see Sections 2 and 2.7.
taxis towards fMLP-OMe and its constrained ana-
 .logues Table 2 . Under control conditions, a dose-
dependent increase of the directed migration in re-
sponse to fMLP-OMe is observed; this reaches a
maximum at 10y9 M and then decreases, as previ-
w x 2qously reported 12 . Any alteration of Ca concen-
tration, either in the extracellular or in the intra-
cellular medium, as well as in both compartments,
proves almost ineffective on the neutrophil chemotac-
tic response towards the peptide. The same result is
w x w 1obtained when an optimal concentration 6 of Thp ,
3x w z 2 x y10Ain is used. D Leu at 10 M, which is a
physiological concentration for neutrophil chemoat-
w xtractants 13 , is unable to induce a chemotactic
response in all the tested conditions; similarly inef-
fective appears when tested at lower as well as higher
 .doses not shown .
4. Discussion
The present findings provide some insight into the
mechanism of signal transduction and suggest that
Ca2q is not a second messenger involved in chemo-
taxis.
Occupancy of neutrophil receptors by fMLP leads
to a great increase in cytosolic free Ca2q concentra-
tion. This appears to occur in two stages: an initial,
transient release of the cation from an intracellular
storage site, followed by a more delayed influx of the
w xcation across the plasma membrane 14 . Increase in
w 2qxCa has been postulated to be a necessary condi-i
tion for neutrophil response to fMLP, because it is
one of the earliest detectable events induced by the
w xexposure of the cells to the formylpeptide 15,16 .
However, a role for cytosolic free Ca2q concentra-
tion, particularly in neutrophil chemotaxis, remains to
be clearly established.
w xWith regard to this point, Haines et al. 17 postu-
lated that chemotactic substances can be divided in
‘‘classical’’ and ‘‘pure’’ chemoattractants. The for-
mer group comprises fMLP and other agents includ-
.ing C5a and interleukin-8 , which evoke a number of
physiological responses by neutrophils, causing an
increase in Ca2q intracellular level. Pure chemoat-
tractants, such as substance P and the transforming
w xgrowth factor b1 18 , are molecules that induce
chemotaxis, but not oxidative burst and granular en-
zyme release: a common feature of these substances
seems to be their inability to influence Ca2q concen-
tration. More recently, it has been reported that the
murine S100 protein, CP-10, also belongs to the pure
chemoattractants, in that it possesses a potent chemo-
tactic activity for neutrophils and monocytesrmacro-
phages, but fails to enhance Ca2q concentration in
w xhuman or mouse neutrophils 19 . An indication that
distinct mechanisms are responsible for the different
neutrophil responses has also come from experiments
w xcarried out utilizing drugs 20 , or pharmacological
w xmanipulation of signal transduction pathways 21 . A
similar conclusion has been reached by studying the
activation of guinea pig neutrophils by wasp chemo-
tactic peptides. In fact, Icaria chemotactic peptide
 .I-CP , like fMLP, has been found to induce multiple
functional responses by neutrophil as well as very
rapid increases in intracellular Ca2q concentration,
w xwhereas Lys7 I-CP, an analogue peptide which in-
duces only chemotaxis, provokes slower enhance-
w xment of the cation level 22 .
The requirement of Ca2q enhancement for chemo-
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taxis has furtherly been questioned following the
w xreport by Laffafian and Hallett 23 who demon-
strated that Ca2q levels, measured in human neu-
trophils moving towards a source of the classical
chemoattractant fMLP, do not significantly change.
They observed an abrupt rise in the cation concentra-
tion only when cells reach the zone of higher peptide
concentration, where chemotaxis stops.
w 1 3xIn this paper, we demonstrate that Thp , Ain
belongs to the pure chemoattractants, because it is a
potent chemotactic agent for human neutrophils, but
y w xinduces neither degranulation nor O release 6 .2
Moreover, the peptide does not alter the intracellular
Ca2q concentration.
w 2qxNeutrophil Ca is significantly increased by thei
w z 2 xfull agonist fMLP-OMe and by D Leu which in-
duces degranulation and Oy production, but is prac-2
tically inactive as chemoattractant. Cation enhance-
ments are inhibited by the presence of U73122, sug-
w 2qxgesting that the mechanism of Ca increase isi
w z 2 xprobably the same for fMLP-OMe and D Leu and
that cation elevation is linked to phospholipase C
w xactivity, as suggested by others 14 .
w 1 3xThe inability of Thp , Ain to increase the cyto-
plasmatic Ca2q concentration could be related to its
poor efficacy in enhancing neutrophil cAMP level, as
w xwe have previously reported 3,4 . Indeed, Verghese
w xet al. 2 demonstrated that TMB-8, which inhibits
w xcalcium influx in neutrophils 24 , completely blocks
the cAMP production induced by fMLP. We ob-
served a similar loss of efficacy in elevation of
nucleotide concentration when neutrophils, incubated
in Ca2q-free medium, were exposed to fMLP-OMe
w z 2 x  .and D Leu E. Fabbri et al., unpublished data .
The present results suggest that Ca2q elevation is
required for Oy production by neutrophils, but not2
for chemotaxis in response to formylpeptides. Ac-
 . w z 2 x ycordingly: i D Leu – which elicits O produc-2
tion but not chemotaxis – significantly increases
2q w 1 3xneutrophil Ca levels, while Thp , Ain , which is
 .a pure chemoattractant, is completely ineffective; ii
the classical chemoattractant fMLP-OMe reaches the
highest chemotactic activity at 10y9 M, a concentra-
tion suboptimal for cation enhancement; this latter,
on the other hand, is maximum when cell migration
towards fMLP-OMe is already reduced. In contrast,
maximal cation enhancements by fMLP-OMe and
w z 2 xD Leu occur at the same concentrations which also
y  .induce optimal O production; iii neutrophil2
chemotaxis is almost insensitive to any variation of
Ca2q concentration, while superoxide anion release is
significantly reduced by the absence of Ca2q in the
extracellular or intracellular medium, and it is com-
pletely abolished by Ca2q chelation in both compart-
ments.
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